Staying in touch with methylphenidate: AHDH and sensory processing. Focus on "methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats"

Journal of Neurophysiology

Volumn 96, Issue 2, 2006, Pages 524-525

  Arnsten, A F T ^a,b   Vijayraghavan, S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; DOPAMINE; METHYLPHENIDATE; NORADRENALIN;

ATTENTION DEFICIT DISORDER; AUDITORY CORTEX; BIOLOGICAL ACTIVITY; BRAIN BLOOD FLOW; DRUG MECHANISM; EDITORIAL; HUMAN; IN VITRO STUDY; LOCOMOTION; NEUROPHYSIOLOGY; PRIORITY JOURNAL; SENSORY ANALYSIS; SENSORY CORTEX; SIGNAL TRANSDUCTION; SOMATOSENSORY CORTEX; UNITED STATES; WAKEFULNESS;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ELECTROPHYSIOLOGY; EVOKED POTENTIALS, SOMATOSENSORY; MALE; METHYLPHENIDATE; NOREPINEPHRINE; RATS; RATS, LONG-EVANS; SOMATOSENSORY CORTEX; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION;

EID: 33746652955     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00373.2006     Document Type: Editorial

References (10)

1. Arnsten AFT and Dudley AG. Methylphenidate improves prefrontal cortical cognitive function through a2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Funct 1: 2, 2005.
2. Devilbiss DM and Waterhouse BD. Norepinephrine exhibits two distinct profiles of action on sensory cortical neuron responses to excitatory synaptic stimuli. Synapse 37: 273-282, 2000.
3. Drouin C, Page M, and Waterhouse B. Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats. J Neurophysiol 96: 622-632, 2006.
4. Foote SL, Freedman FE, and Oliver AP. Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex. Brain Res 86: 229-242, 1975.
5. Kuczenski R and Segal DS. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22: 7264-7271, 2002.
6. Lee JS, Kim BN, Kang E, Lee DS, Kim YK, Chung JK, Lee MC, and Cho SC. Regional cerebral blood flow in children with attention deficit hyperactivity disorder: comparison before and after methylphenidate treatment. Hum Brain Mapp 24: 157-164, 2005.
7. McCormick DA and Pape HC. Noradrenergic and serotonergic modulation of a hyperpolarization-activated cation current in thalamic relay neurones. J Physiol 431: 319-342, 1990.
8. Parush S, Sohmer H, Steinberg A, and Kaitz M. Somatosensory functioning in children with attention deficit hyperactivity disorder. Dev Med Child Neurol 39: 464-468, 1997.
9. Rapoport JL and Inoff-Germain G. Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: update 2002. J Atten Disord 6: S57-60, 2002.
10. Yamaguchi S and Knight RT. Gating of somatosensory input by human prefrontal cortex. Brain Res 521: 281-288, 1990.